Why We Think Seach Medical Group Ltd's (TLV:SEMG) CEO Compensation Is Not Excessive At All
Jun 25
Have your own idea? Try our Stock Screener
Israeli (TA) Pharma Industry Analysis
UpdatedJul 14, 2025
DataAggregated Company Financials
Companies8
- 7D-0.7%
- 3M2.3%
- 1Y-34.0%
- YTDn/a
The Pharma is pretty flat in the last 7 days, but Seach Medical Group has stood out, gaining 4.6%. Unfortunately though, the industry is down 33% over the past 12 months.
Industry Valuation and Performance
Has the Israeli Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 14 Jul 2025 | ₪566.2m | ₪716.7m | -₪71,474,767.90 | 30x | -7.9x | 0.8x |
| Wed, 11 Jun 2025 | ₪580.3m | ₪716.7m | -₪72,129,279.40 | 32.7x | -8x | 0.8x |
| Fri, 09 May 2025 | ₪591.3m | ₪732.8m | -₪82,045,140.00 | 14.9x | -7.2x | 0.8x |
| Sun, 06 Apr 2025 | ₪544.5m | ₪766.6m | -₪81,109,008.00 | 14.1x | -6.7x | 0.7x |
| Tue, 04 Mar 2025 | ₪668.4m | ₪828.6m | -₪180,447,862.40 | 21.8x | -3.7x | 0.8x |
| Thu, 30 Jan 2025 | ₪668.5m | ₪828.6m | -₪180,555,116.00 | 20.7x | -3.7x | 0.8x |
| Sat, 28 Dec 2024 | ₪668.5m | ₪828.6m | -₪181,513,403.60 | 19.9x | -3.7x | 0.8x |
| Mon, 25 Nov 2024 | ₪606.7m | ₪816.0m | -₪184,026,045.40 | 23.8x | -3.3x | 0.7x |
| Wed, 23 Oct 2024 | ₪637.8m | ₪808.7m | -₪206,068,607.90 | 22.6x | -3.1x | 0.8x |
| Fri, 20 Sep 2024 | ₪669.3m | ₪810.4m | -₪244,502,229.80 | 22.1x | -2.7x | 0.8x |
| Sun, 18 Aug 2024 | ₪620.1m | ₪901.7m | -₪251,714,501.80 | n/a | -2.5x | 0.7x |
| Tue, 16 Jul 2024 | ₪712.1m | ₪901.7m | -₪260,781,635.20 | n/a | -2.7x | 0.8x |
| Thu, 13 Jun 2024 | ₪710.3m | ₪891.0m | -₪257,845,350.40 | n/a | -2.8x | 0.8x |
| Sat, 11 May 2024 | ₪853.4m | ₪886.2m | -₪260,802,536.00 | n/a | -3.3x | 1x |
| Mon, 08 Apr 2024 | ₪775.8m | ₪950.0m | -₪182,314,128.00 | 21.3x | -4.3x | 0.8x |
| Wed, 06 Mar 2024 | ₪656.1m | ₪972.3m | -₪206,977,792.00 | 15x | -3.2x | 0.7x |
| Fri, 02 Feb 2024 | ₪549.9m | ₪972.3m | -₪212,334,592.00 | 10x | -2.6x | 0.6x |
| Sun, 31 Dec 2023 | ₪563.8m | ₪972.3m | -₪211,671,107.00 | 10x | -2.7x | 0.6x |
| Tue, 28 Nov 2023 | ₪585.6m | ₪958.8m | -₪208,480,112.00 | 9.7x | -2.8x | 0.6x |
| Thu, 26 Oct 2023 | ₪634.4m | ₪958.8m | -₪215,032,868.00 | 9.4x | -3x | 0.7x |
| Sat, 23 Sep 2023 | ₪681.9m | ₪958.8m | -₪209,747,140.00 | 13.3x | -3.3x | 0.7x |
| Mon, 21 Aug 2023 | ₪644.1m | ₪918.8m | -₪128,402,228.00 | 8x | -5x | 0.7x |
| Wed, 19 Jul 2023 | ₪676.8m | ₪918.8m | -₪124,544,728.00 | 8.6x | -5.4x | 0.7x |
| Fri, 16 Jun 2023 | ₪776.8m | ₪918.8m | -₪123,824,816.00 | 11x | -6.3x | 0.8x |
| Sun, 14 May 2023 | ₪850.1m | ₪887.2m | -₪122,361,736.00 | 9x | -6.9x | 1x |
| Tue, 11 Apr 2023 | ₪850.0m | ₪855.1m | -₪86,552,318.00 | 10.2x | -9.8x | 1x |
| Thu, 09 Mar 2023 | ₪836.5m | ₪815.6m | -₪70,655,622.00 | 12.7x | -11.8x | 1x |
| Sat, 04 Feb 2023 | ₪1.1b | ₪739.7m | -₪55,876,525.00 | 18.1x | -19.1x | 1.4x |
| Mon, 02 Jan 2023 | ₪964.0m | ₪739.7m | -₪57,563,575.00 | 16.8x | -16.7x | 1.3x |
| Wed, 30 Nov 2022 | ₪1.2b | ₪728.3m | -₪56,365,788.00 | 22.9x | -22x | 1.7x |
| Fri, 28 Oct 2022 | ₪1.3b | ₪689.4m | -₪60,046,482.00 | 31.4x | -21.4x | 1.9x |
| Sun, 25 Sep 2022 | ₪1.3b | ₪689.4m | -₪60,176,220.00 | 30.1x | -21.6x | 1.9x |
| Tue, 23 Aug 2022 | ₪1.5b | ₪781.4m | -₪106,506,771.00 | 33.4x | -14.3x | 2x |
| Thu, 21 Jul 2022 | ₪1.6b | ₪731.4m | -₪118,932,006.00 | 41.1x | -13.6x | 2.2x |
Price to Earnings Ratio
-13.6x
Current Industry PE
- Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading close to its 3-year average PS ratio of 0.97x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.
Industry Comparison
How does Israeli Pharma compare with similar industries?
| IL Market | -1.67% | |
| Healthcare | -1.73% | |
| Pharma | -0.67% | |
| Pharma | -0.67% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SEMG Seach Medical Group | ₪2.85 | 3.4% +₪3.1m | 93.6% | PE6.3x | |
| INCR InterCure | ₪5.10 | 0.4% +₪896.1k | -41.1% | PS1x | |
| REKA Rekah Pharmaceutical Industry | ₪12.52 | 0.2% +₪342.4k | -18.1% | PE55.1x |